tiprankstipranks
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market

Silence Therapeutics (SLN) Income Statement

Compare
154 Followers

Silence Therapeutics Income Statement

Last quarter (Q4 2024), Silence Therapeutics's total revenue was £24.33M, an increase of 1059.02% from the same quarter last year. In Q4, Silence Therapeutics's net income was £14.17M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 43.26M£ 25.38M£ 17.50M£ 12.41M£ 5.48M
Gross Profit
£ 31.45M£ 15.06M£ 6.62M£ 4.96M£ 1.72M
Operating Expenses
£ 94.77M£ 64.66M£ 55.21M£ 50.77M£ 37.56M
Depreciation and Amortization
£ 593.00K£ 498.00K£ 482.00K£ 427.00K£ 496.00K
EBITDA
£ -48.99M£ -49.78M£ -47.88M£ -45.42M£ -35.53M
Operating Income
£ -63.32M£ -49.60M£ -48.59M£ -45.81M£ -35.85M
Other Income/Expenses
£ 18.86M£ -706.00K£ 1.23M£ -42.00K£ -194.00K
Pretax Income
£ -44.46M£ -50.31M£ -47.37M£ -45.86M£ -36.04M
Net Income
£ -45.31M£ -43.27M£ -40.49M£ -39.41M£ -32.55M
Per Share Metrics
Basic EPS
£ -0.98£ -0.39£ -1.26£ -1.33£ -1.19
Diluted EPS
£ -0.98£ -0.39£ -1.26£ -1.33£ -1.19
Weighted Average Shares Outstanding
46.25M 111.28M 32.19M 29.65M 27.26M
Weighted Average Shares Outstanding (Diluted)
46.25M 111.28M 32.19M 29.65M 27.26M
Currency in GBP

Silence Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis